This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Basic research is the foundational theorizing and testing scientists pursue in order to advance their understanding of a phenomenon in the natural world, and, increasingly, in the digital realm. Biomedical engineer Dr. Joe Alexander, the former medical director at pharmaceutical giant Pfizer, grabbed a distinguished scientist post, as well.
based life sciences and high-tech manufacturing companies sheds light on how digitaltransformation – and the rising role of third-party partners – have combined to create unprecedented operational challenges in the brave new world of digital commerce. A recent poll of some 300 senior executives from U.S.-based
Reaching your DigitalTransformation goals often requires the addition of new software solutions. PoC is an essential tool to determine the viability of any proposed technology and an enabling strategy for digitaltransformation. But, shopping around for software can be a challenge. Want more episodes like this?
According to AIIM research, 70% of AIIM members say that getting the right information, to the right person, at the right time is at the heart of their digitaltransformation challenge. Increased agility, service, and innovation are all hallmarks of digitaltransformation.
In the blink of an eye, COVID-19 has disrupted all industries and quickly accelerated their plans for digitaltransformation. There’s a clear connection between business process modeling and digitaltransformation initiatives.
Related: Identity governance issues in the age of digitaltransformation. In this digitallytransformed environment, maintaining perimeter defenses still has a place. Identity governance and administration, or IGA , has suddenly become a front-burner matter at many enterprises.
In 2022, many if not most pharmaceutical, medical device, and other life sciences companies established strategies to innovate digital health technology complementary to their existing strategic focus. The digitaltransformation of the life sciences industry is still widely unfolding across the marketplace.
Pharmaceutical and Life Science are good examples of industries that are feeling the pain. Start by downloading the latest tip sheet from AIIM, “ Co-Authoring Tools Provide the Right Prescription for Pharmaceutical and Life Science Success.” FREE Tip Sheet: New Tools Provide the Right Prescription for Co-authoring Success].
Every organization — from mom and pop shops to pharmaceutical manufacturers — must adopt tools and techniques for providing the hyper-personalized experiences customers require at every touchpoint in their journey. . Big ideas like Digitaltransformation initiatives. Your Customer Experience Is Your Most Valuable Asset.
Roles and titles will continue to evolve , and as the business and IT sides of the organization continue to come together in the face of digitaltransformation , how these teams are organized, where they report, and the types of projects they focus on are sure to change over time. erwin, Inc.’s
These initiatives can include digitaltransformation, cloud migration, portfolio and infrastructure rationalization, regulatory compliance, mergers and acquisitions, and innovation management. Regulatory Compliance Through Enterprise Architecture & Business Process Modeling Software.
With COVID-19 accelerating digitaltransformation in nearly every industry, we’ve seen companies adopt technology at a much faster rate than expected, creating hypergrowth in data and a tremendous need for corralling it. Reltio’s customer base was primarily in the pharmaceutical industry out of the gate.
However, the next few years are about to see major new legislation in the EU that could result in major disruption to Life Sciences, Pharmaceutical and Healthcare companies – wherever they are. The Life Sciences sector is used to constant regulatory change.
Regulations such as the General Data Protection Regulation (GDPR), Health Insurance and Portability Accountability Act (HIPAA), Basel Committee on Banking Supervision (BCBS) and The California Consumer Privacy Act (CCPA) particularly affect sectors such as finance, retail, healthcare and pharmaceutical/life sciences. Digitaltransformation.
That’s the type of problem that these specialty quantum computers can solve.” Another exciting NTT Research project is headed by Dr. Joe Alexander the former medical director at pharmaceutical giant Pfizer. Alexander now heads up studies to advance “digital twin” technology, focusing on eventual deployment of a virtual human heart.
The life sciences industry faces many challenges driving a critical need for rapid digitaltransformation with data-driven decision-making as the backbone for change. Data enables pharma companies to meet these challenges head-on and leverage the power of digital technologies to improve outcomes for patients and drive business success.
“But didn’t your pharmaceutical company initiated digitaltransformation recently?” When modern businesses prioritize their digitaltransformation activities, the biggest challenge they face is taming their data. ” She lamented. ” “You do?” Janine was surprised.
Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new treatments that improve patient outcomes. At OpenText™, the Life Sciences team is committed to delivering better intelligent content services that drive productivity, growth and a lasting competitive advantage.
Data leaders and architects want to accelerate their company’s digitaltransformation and enable connected customer experiences with connected data. At Reltio, we’re on a mission to enable digitaltransformation by delivering a single source of truth for enterprise data designed for the digital experience economy.
Customers interviewed in the study were from the pharmaceuticals, technology, insurance and retail industries. Modern MDM: Simpler, Cost Effective DigitalTransformation. Our composite customer customized omnichannel marketing efforts more efficiently by targeting specific segments to maximize their efficacy.
ABBYY continued to see strong demand for its Digital Intelligence solutions in FY19, with customers including one of the world’s largest pharmaceutical companies, smart infrastructure solutions company Costain , a global medical supply manufacturer and distributor Medline , and other leading enterprises across industries.
Some of the world's top enterprises now run on Reltio, including 14 of the Fortune 100, and 9 of the top 10 pharmaceutical companies and several globally recognized customers, including AstraZeneca, Takeda, Empire Life Insurance, and Fulton Bank, switched from legacy to modern MDM solutions.
They need data to drive their digitaltransformation, to deliver connected customer experiences, to gain deeper customer insights and to drive innovation. . They need a new way to manage their data. They need an enterprise-wide approach. They need speed, agility and scale so they can respond faster to changing market conditions.
pharmaceuticals, aerospace, etc.), Taking MES software to the next level A manufacturing execution system (MES) is an important means of data collection and an important part of digitaltransformation for manufacturers. Compliance and security: For industries with strict regulatory requirements (e.g.,
As a pioneer in data unification and management, Reltio® continues to push the frontiers in empowering customers to realize the full potential of their data and enable digitaltransformation. Reltio now proudly serves all of the Top 10 Pharmaceutical companies in the world.¹ As measured by revenue, as of 2024.
AIOps is one of the fastest ways to boost ROI from digitaltransformation investments. Pharmaceuticals For the life sciences industry, drug discovery and production require an immense amount of data collection, collation, processing and analysis.
OpenText™ is thrilled to announce the launch of OpenText Content Cloud™ for Life Sciences, an innovative new offering that brings the proven productivity and governance capabilities of OpenText™ Documentum™ for Life Sciences to a cloud environment.
For the past three years, OpenText™ Enterprise World in July has been the destination of choice for business leaders and partners who have invested in Enterprise Information Management with OpenText.
The life sciences industry has seen monumental change over the past few years. From the Covid-19 pandemic to a spike in investment, coupled with rising inflation and economic instability, the industry has been drenched in uncertainty and unpredictability. However, life sciences leaders remain optimistic about the year ahead.
Simplicity. That’s what every Life Sciences professional working with regulated business processes needs today. That’s exactly what they’re getting with the intuitive user experience and efficient cloud-based access of our new OpenText™ Life Sciences Express. Here’s why simplicity is so important.
If you work in the Life Sciences industry, your head will be nodding in confirmation while reading Forrester’s The Five Big Trends report, especially the part that states employee productivity has emerged as the second biggest driver for ECM investment in 2019. for OpenText Life Sciences Express appeared first on OpenText Blogs.
When major acquisitions happen, market analysts, competitors, customers, and employees alike are watching closely to determine what’s next. In fact, employees like me were not terribly nervous when OpenText™ – a long-standing leader in enterprise content management – acquired Dell EMC’s Enterprise Content Division in January 2017.
The healthcare and life sciences industry are at an inflection point in its digitaltransformation journey. Across all segments of the industry – from payer, provider, biotech and pharmaceutical – organizations are ramping up on their digitaltransformation initiatives with a renewed sense of urgency.
This also extends to industry-specific other compliance mandates such as those in healthcare, pharmaceutical and the financial services industries. DigitalTransformation: Once in a while, a technological revolution turns the nature of business on its head. The result?
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content